Coronary microvascular disease in humans

Japanese Heart Journal

Volumn 40, Issue 2, 1999, Pages 97-108

  Mohri, Masahiro ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Coronary flow reserve; Endothelial dysfunction; Myocardial ischemia; Nitric oxide

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; ARGININE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ERGOMETRINE; ESTRADIOL; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENALINE; LOW DENSITY LIPOPROTEIN; N(G) METHYLARGININE; NITRIC OXIDE; SIMVASTATIN; STATIN; VASOCONSTRICTOR AGENT;

ANGIOCARDIOGRAPHY; APHERESIS; BLOOD VESSEL TONE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE SEVERITY; ELECTROCARDIOGRAM; EPICARDIUM; EPITHELIUM CELL; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SYNDROME X; VASCULAR ENDOTHELIUM; VASODILATATION;

ANGINA PECTORIS; CARDIOMYOPATHY, DILATED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; NITRIC OXIDE; RISK FACTORS;

EID: 0032893205     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.40.97     Document Type: Review

References (90)

1. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32: 375-6.
2. Kemp HG Jr. Syndrome X revisited. J Am Coll Cardiol 1991; 17: 507-8.
3. Cannon RO, Epstein SE. Microvascular angina as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61: 1338-43.
4. Kaski JC, Elliott PM. Angina pectoris and normal coronary arteriograms: clinical presentation and hemodynamic characteristics. Am J Cardiol 1995; 76: 35D-42D.
5. Kaski JC. Chest pain and normal coronary arteriograms: role of "microvascular spasm". Lancet 1998; 351: 1144-5.
6. Opherk D, Zebe H, Weihe E, et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation 1981; 63: 817-25.
7. Cannon RO, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1983; 1: 1359-73.
8. Greenberg MA, Grose RM, Neuburger N, Silverman R, Strain JE, Cohen MV. Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries. J Am Coll Cardiol 1987; 9: 743-51.
9. Motz W, Vogt M, Rabenau O, Scheler S, Lückhoff A, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991; 68: 996-1003.
10. Camici PG, Marraccini P, Lorenzoni R, et al. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol 1991; 17: 1461-70.
11. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659-64.
12. Galassi AR, Crea F, Araujo LI, et al. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol 1993; 72: 134-9.
13. Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96: 3390-5.
14. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. Circulation 1996; 94: 130-4.
15. Bellamy MF, Goodfellow J, Tweddel AC, et al. Oral L-arginine improves exercise tolerance and flow-mediated endothelial dysfunction in microvascular angina (abstract). Circulation 1996; 94 (suppl 1): I-425.
16. Kaski JC, Elliott PM, Salomone O, et al. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995; 74: 620-4.
17. Hoffmann E, Assennato P, Donatelli M, Colletti I, Valenti TM. Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms. Am Heart J 1998; 135: 684-8.
18. Inobe Y, Kagiyama K, Monta E, et al. Role of adenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurements and thallium-201 myocardial single-photon emission computed tomography. J Am Coll Cardiol 1996; 28: 890-6.
19. Kaski JC, Rosano GMC, Nihoyannopoulos P, Collins P, Maseri A, Poole-Wilson P. Cardiac syndrome X: clinical characteristics and left ventricular function: a long-term follow-up study. J Am Coll Cardiol 1995; 25: 807-14.
20. Kaski JC, Crea F, Nihoyannopoulos P, Hackett D, Maseri A. Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol 1986; 58: 1242-7.
21. Clarke JG, Davies GJ, Kerwin R, et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1987; i: 1057-9.
22. Mohri M, Koyanagi M, Egashira K, et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165-9.
23. Epstein SE, Cannon RO. Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. J Am Coll Cardiol 1986; 8: 459-61.
24. Maseri A, Crea F, Kaski JC, Crake T. Mechanism of angina pectoris in syndrome X. J Am Coll Cardiol 1991; 17: 499-506.
25. Richardson PJ, Livesley B, Oram S, Olsen EGJ, Armstrong P. Angina pectoris with normal coronary arteries: transvenous myocardial biopsy in diagnosis. Lancet 1974; 2: 677-80.
26. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and large patent coronary arteries. Circulation 1986; 74: 964-72.
27. Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol 1994; 43: 139-50.
28. Ito A, Egashira K, Kadokami T, et al. Chronic inhibition of endothelium-derived nitric oxide causes structural and functional abnormalities in coronary microvessels but not in the large epicardial vessels in pigs. Circulation 1995; 92: 2636-44.
29. Kadokami T, Egashira K, Kuwata K, et al. Altered serotonin receptor subtypes mediate coronary microvascular hyperreactivity in pigs with chronic inhibition of nitric oxide synthesis. Circulation 1996; 94: 182-9.
30. Vogt M, Strauer BE. Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease. [Review] [34 refs]. Am J Cardiol 1995; 76: 48D-53D.
31. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (small vessel) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-57.
32. Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75: 1130-9.
33. Krams R, Kofflanrd MJ, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998; 97: 230-3.
34. Brush JE Jr, Cannon RO, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302-7.
35. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy. Circ Res 1981; 48: 76-87.
36. Bache RJ, Arentzen CE, Simon AB, Vrobel TR. Abnormalities in myocardial perfusion during tachycardia in dogs with left ventricular hypertrophy: metabolic evidence for myocardial ischemia. Circulation. 1984; 69: 409-17.
37. Zhang J, Merkle H, Hendrich K, et al. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 1993; 92: 993-1003.
38. Marcus ML, Harrison DG, Chilian WM, et al. Alterations in the coronary circulation in hypertrophied ventricles. Circulation 1987; 75 (suppl I): I-19-I-25.
39. Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J, Kübler W. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1-7.
40. Treasure CB, Klein JE, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.
41. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92: 652-62.
42. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension: different responses to acetylcholine and substance P. Hypertension 1995; 25: 201-6.
43. Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia: comparison of acetylcholine and substance P. Circulation 1997; 95: 104-10.
44. Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998; 32: 137-53.
45. Gimelli A, Schneider-Eicke J, Neglia D, et al. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. J Am Coll Cardiol 1998; 31: 366-73.
46. Mohri M, Koyanagi M, Egashira K, Takeshita A. Coronary microvascular dysfunction contributes to myocardial ischaemia in hypertensive patients with angina and normal coronary arteriograms. Eur Heart J 1998; 19 (abstr suppl): 474.
47. Kitakaze M, Minamino T, Node K, et al. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation 1995; 92: 950-61.
48. Duncker DJ, Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res 1994; 74: 629-40.
49. Mohri M, Tagawa H, Ichiki T, Tagawa T, Koyanagi M, Hirooka Y. Endogeneous nitric oxide prevents pacing-induced myocardial ischemia in patients with hypertensive left ventricular hypertrophy. Circulation 1997; 96: I-72.
50. White FC, Sanders M, Peterson T, Bloor CM. Ischemic myocardial injury after exercise stress in the pressure-overloaded heart. Am J Pathol 1979; 97: 473-88.
51. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res 1989; 65: 971-80.
52. Ilia R, Carmel S, Cafri C, Gueron M. Coronary collaterals in patients with normal and impaired left ventricular systolic function. Int J Cardiol 1998; 63: 151-3.
53. Egashira K, Inou T, Hirooka Y, et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 1993; 91: 29-37.
54. Egashira K, Hirooka Y, Kai H, et al. Reduction of serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89: 2519-24.
55. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo: focus on hypercholesterolemia. Hypertension 1991; 18: II90-II99.
56. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991; 338: 1546-50.
57. Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95: 1747-55.
58. Chowienczyk P, Ritter J. Arginine: NO more than a simple amino acid? Lancet 1997; 350: 901-2.
59. Keaney JF, Vita JA. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 1995; 38: 129-54.
60. Wilson RF, Johnson MR, Marcus ML, et al. The effect of coronary angioplasty on coronary flow reserve. Circulation 1988; 77: 873-85.
61. Tagawa H, Mohri M, Ichiki T, Egashira K. L-arginine attenuates tachycardia-induced myocardial ischemia in patients with extensive coronary artery disease. Circulation 1997; 96: I-316.
62. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995; 91: 635-40.
63. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094-100.
64. Horwitz LD, Curry GC, Parkey RW, Bonte FJ. Effect of isoproterenol on coronary blood flow in primary myocardial disease. Circulation 1974; 50: 560-4.
65. Pasternac A, Noble J, Streulens Y, Elie R, Henschke C, Bourassa MG. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 1982; 65: 778-89.
66. Neglia D, Parodi O, Gallopin M, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. Circulation 1995; 92: 796-804.
67. Opherk D, Schwarz F, Mall G, Manthey J, Baller D, Kübler W. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients. Am J Cardiol 1983; 51: 1657-62.
68. Nitenberg A, Foult J-M, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol 1985; 55: 748-54.
69. Treasure CB, Vita JA, Cox DA, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990; 81: 772-9.
70. Inoue T, Sakai Y, Morooka S, et al. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J 1994; 127: 376-81.
71. Cannon RO, Cunnion RE, Parrillo JE, et al. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. J Am Coll Cardiol 1987; 10: 1190-200.
72. Wang J, Seyedi N, Xu X-B, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 1994; 266: H670-H680.
73. Kichuk MR, Seyedi N, Zhang X, et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 1996; 94: 44-51.
74. Smith CJ, Sun D, Hoegler C, et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996; 78: 58-64.
75. Mohri M, Egashira K, Tagawa T, et al. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension 1997; 30: 50-6.
76. Kuga T, Mohri M, Egashira K, et al. Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. J Am Coll Cardiol 1997; 30: 108-12.
77. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol 1994; 23: 652-7.
78. Antony I, Lerebours G, Nitenberg A. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation 1996; 94: 3115-22.
79. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996; 27: 1031-8.
80. Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94: 258-65.
81. Schalifer JD, Wargovich TJ, O'Neill B, et al. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. Am J Cardiol 1997; 80: 1594-7.
82. Mohri M, Egashira K, Kuga T, Kubota T, Takeshita A. Angiotensin-converting enzyme inhibition with intracoronary enalaprilat augments metabolic coronary vasodilation via endothelium-dependent mechanism in the human failing heart. Eur Heart J 1995; 16 (Abstr. suppl): 455.
83. Rosano GM, Peters NS, Lefroy D, et al. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996; 28: 1500-5.
84. Sack MN, Rader DJ, Cannon RO 3rd. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994; 343: 269-70.
85. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.
86. Gilligan DM, Quyyumi AA, Cannon RO 3rd. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-51.
87. Gould KL. Reversal of coronary atherosclerosis. Circulation 1994; 90: 1558-71.
88. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolimic humans. Circulation 1997; 95: 76-82.
89. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-31.
90. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1988; 97: 1129-35.